Top Tweets for #ILCT
Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties | Inorganic Chemistry https://t.co/K2UneL3S08 Alberto, Cameron, McFarland, and co-workers @InorgChem #ruthenium #oligothienyl #fluorinated #MLCT #ILCT #PSs

The International Linked Clinical Trials (iLCT) programme is continuing to progress its ongoing efforts to ultimately expand the number of treatment options available for people living with #Parkinsons. Find out more at: https://t.co/1tKhzrhzRC
#CureParkinsons #ILCT

Just back from the @CureParkinsonsT international Linked Clinical Trials Committee #ILCT meeting. Many negative #PD disease-modifying trials, but so many reasons for hope! A quote from Nelson Mandela applies here: "I never lose, I either win or learn"
https://t.co/0YY1m3wHm2

The Cairn Gang is still fundraising for The Cure Parkinson's Trust. @CureParkinsonsT #ILCT #CureParkinsons #ParkinsonsResearch. Check out our @JustGiving page and please donate if you can. Thank you! #JustGiving https://t.co/M6HBmvNMQy
(1/2) In 2012 Cure Parkinson’s set up the International Linked Clinical Trials (iLCT) programme to speed up the search for potential treatments for Parkinson’s.
#ILCT #CureParkinsons #ParkinsonsResearch

(1/2) The dedicated International Linked Clinical Trials (iLCT) committee will meet this weekend at Cumberland Lodge, Windsor to evaluate and rank a selection of potentially disease-modifying treatments for Parkinson’s.
#ILCT #CureParkinsons #ParkinsonsResearch

Homoleptic Alkynylphosphonium Au(I) Complexes as Push–Pull Phosphorescent Emitters https://t.co/NvBVn3eSf5 Petrovskii, Grachova, and co-workers @InorgChem #gold #alkynl #phosphonium #push #pull #phosphorescence #PMMA #MLCT #ILCT #DpiA

2023 is shaping up to be an interesting year of research focused on disease-modification for Parkinson’s - see what's ahead in our calendar
#Parkinsons #clinicaltrials #research #iLCT
https://t.co/KUotM8Pskc
C-ABL is a promising target for drug treatment in Parkinson's - find out more about this line of research
@VAInstitute
#Parkinsons #iLCT #clinicaltrials
https://t.co/Nz870GcT89
(1/2) Ambroxol was prioritised for clinical trial in people with Parkinson’s through our #iLCT programme and Cure Parkinson’s has been the impetus behind the new phase 3 ambroxol trial alongside @VAInstitute and the John Black Charitable Foundation.
#ambroxolphase3

@VAInstitute @ParkinsonsUK @UCLIoN @TonySchapira (3/3) The ambroxol trial was prioritised via our #iLCT Funded by Cure Parkinson’s and its strategic partners @VAInstitute and the John Black Charitable Foundation and by the Parkinson’s Virtual Biotech the drug discovery and development arm of @ParkinsonsUK
#ambroxolphase3
Deep Blue Phosphorescence from Platinum Complexes Featuring Cyclometalated N-Pyridyl Carbazole Ligands with Monocarborane Clusters (CB11H12–) https://t.co/b7q6H8TfuQ Zhang and co-workers @InorgChem #platinum #pyridyl #carbazole #monocarborane #deep_blue #ILCT #MLCT #PhOLED #TDDFT

Congratulations to this year’s winners of the #TomIsaacsAward – Drs Michael Okun and Ray Dorsey, co-authors of the breakthrough book ‘Ending Parkinson’s Disease: A Prescription for Action’! Former #iLCT chair, Dr Patrik Brundin, also received a special recognition award!

Tonight @Roche visits Grand Rapids, Michigan! Time for two days of Grand Challenges in #Parkinson’s Disease @VAInstitute with @ravi_jagasia @DrGennaroPagano
Thank you @CureParkinsonsT for a delicious dinner after hard work with #iLCT

Our International Linked Clinical Trials programme in collaboration with @VAInstitute #iLCT Find out more:
https://t.co/1xDAqm5cEb
https://t.co/2mWUFCqKb6
A beautiful morning @VAInstitute @CureParkinsonsT ahead of day two of the international Linked Clinical Trials Meeting in Grand Rapids.

Join the Rallying Facebook group ahead of this year’s #PDRallying to the Challenge meeting and post any comments or questions you have about the theme ‘Modifying Progression – From Molecules to Trials’: https://t.co/x66yuMDtw8
#PDrallying #iLCT #LinkedClinicalTrials #Parkinsons

The International Linked Clinical Trials (iLCT) meeting will be on 26 and 27 September at Grand Rapids, in collaboration with @VAInstitute. We are also thrilled to announce Professor David K. Simon is the new chair of the #iLCT programme! To read more: https://t.co/8s0II3fc7F

@BRAINCURES @adpdnet @BrundinPatrik @M_SuarezCalvet @touteiro @IMI_AMYPAD @MaluTansey @LashuelLab @nfranzme @JeanGeorgesAE @AlzheimerEurope @NicholasAshton @SpillantiniLab @biofinder_study @Cara_Croft @ParkinsonDotOrg @ScienceofPD @ParkinsonsUK @InnovationFixer @dominey_thea @journal_PD @MichaelJFoxOrg @ASAP_Research @euparkinsons @PFResearchTeam @eupatientsforum @TeamParkinsons @SfNtweets @FENSorg @profsimonlewis @DrJ_Fonseca @KateZhongMD @NinadAmondikar1 @MSPBrainBank @predictPD @AddisonClare @DrArthurRoach @Shakyteam @LabGandhi @RichelleFlan @julie_physio @BoytonBoy @ProfJimRichards @FackrellRobin @ParkinsonsDoc @Lundbeck Thank you for the mention! We're very proud of our #iLCT and these stats.
Our International Linked Clinical Trials committee prioritised Anle138b for clinical testing to determine its potential to slow the progression of #Parkinsons #iLCT #clinicaltrials @VAInstitute
https://t.co/hDA5S8UwzJ
Most Popular Users

Elon Musk 
@elonmusk
241.2M followers

Barack Obama 
@barackobama
119.1M followers

Cristiano Ronaldo 
@cristiano
112.6M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.2M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.4M followers

KATY PERRY 
@katyperry
88.9M followers

Taylor Swift 
@taylorswift13
82.8M followers

Lady Gaga 
@ladygaga
74.3M followers

Virat Kohli 
@imvkohli
71.7M followers

Kim Kardashian 
@kimkardashian
70.4M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
64.6M followers

Bill Gates 
@billgates
64.5M followers

The Ellen Show
@theellenshow
62.4M followers

Selena Gomez 
@selenagomez
61.9M followers

CNN 
@cnn
61.8M followers

X 
@x
60.8M followers






